Related Experiment Video
Updated: Mar 28, 2026
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Design and Baseline Characteristics of Participants in the Clarifying the Optimal Application of Selective Laser
Tony Realini1, G K Balasubramani2, Tanya Kenkre2
1Department of Ophthalmology and Visual Sciences, School of Medicine, West Virginia University, Morgantown, WV.
Prcis:
COAST was designed to investigate alternate approaches to SLT to provide more effective long-term disease control without the need for alternate therapies such as medications or surgery. Methodology and baseline participant characteristics are described.
Purpose:
To describe the hypothesis and methodology for the ongoing Clarifying the Optimal Application of selective laser trabeculoplasty (SLT) therapy (COAST) Trial 1 and participants' baseline characteristics.
Methods:
COAST Trial 1 is a multicenter randomized trial comparing standard-energy versus low-energy SLT as initial therapy for newly diagnosed ocular hypertension (OHT) or mild-moderate primary open angle glaucoma (POAG). The hypothesis is that 12-month survival following low-energy SLT will be noninferior to 12-month survival with standard-energy SLT.
Results:
When enrollment ceased, 418 participants had been randomized to low-energy (n=203) or standard-energy (n=215) SLT. Demographic and clinical characteristics were similar between groups. Most participants were White (66.5% and 67.9%, respectively) or Black/African American (25.1% and 21.4%, respectively). Qualifying diagnoses were mild POAG (59.6% and 62.1%, respectively), ocular hypertension (32.8% and 30.5%), and moderate POAG (7.6% and 7.4%). Mean optical coherence tomography retinal nerve fiber layer thickness was 81.9 and 82.0 µm, respectively; mean visual field mean deviation was -1.6 dB in both groups. Mean baseline IOP was highest among eyes with ocular hypertension (24.5 and 24.4 mm Hg, respectively) and lower in eyes with mild (21.8 and 21.4 mm Hg) and moderate POAG (22.0 and 21.0 mm Hg).
Conclusions:
COAST is a timely and potentially highly impactful trial that will clarify the optimal utilization of SLT for long-term glaucoma management without the need for alternative therapies such as medications or surgery. The COAST sample closely resembles the population of newly diagnosed POAG/OHT patients for whom primary SLT would be appropriate, optimizing generalizability of study results when available.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Related Concept Videos
01:11Clinical Trials: Overview
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:20Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
01:16Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:15Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...